Ferritin in hypertensive and diabetic women before and after bariatric surgery
Carregando...
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
TĂtulo da Revista
ISSN da Revista
TĂtulo de Volume
Editor
Aula Medica Ediciones
Tipo
Artigo
Direito de acesso
Acesso aberto

Resumo
Resumo (inglĂȘs)
In addition to its important role as marker of iron stores, serum ferritin is a marker of systemic inflammation, and obesity has been associated with chronic inflammation.Objective: To verify, six months after surgery, the effect of bariatric surgery on the serum ferritin of women who were hypertensive, diabetic, or comorbidity free before surgery.Sample and methods: This retrospective study included 200 women aged 20 to 45 years, with a body mass index (BMI) equal to or greater than 35 kg/m(2), submitted to Roux-en-Y gastric bypass (RYGB). Seventy of these women were hypertensive, forty had type 2 diabetes (T2D), and ninety were comorbidity free (CF). They were assessed before and six months after surgery. Anthropometric, laboratory (serum ferritin and hemoglobin), and comorbidity-related data were collected from their medical records.Results: Before surgery, women with comorbidities were older, the hypertensives had higher BMI, and the diabetics had higher serum ferritin levels than the CF women. The study comorbidities had resolved in 68% of the hypertensive women and 86% of the diabetic women six months after RYGB. Also at this time, the serum ferritin of hypertensive women decreased from 110.1 +/- 86.3 to 88.7 +/- 80.5 ng/dL and of diabetic women, from 164.8 +/- 133.4 to 101.2 +/- 97.7 ng/dL (p<0.05); hemoglobin also decreased in hypertensive and CF women (p>0.05).Conclusion: High ferritin in premenopausal obese women was associated with the main obesity-related comorbidities, and these comorbidities determined the reduction of serum ferritin after bariatric surgery.
Resumo (espanhol)
AdemĂĄs de importante marcador de las reservas de hierro, la ferritina sĂ©rica es un marcador de la inflamaciĂłn sistĂ©mica, mientras que la obesidad se ha asociado con la inflamaciĂłn crĂłnica. Objetivo: Identificar, despuĂ©s de 6 meses, el efecto de la cirugĂa bariĂĄtrica sobre los niveles de ferritina sĂ©rica en hipertensos, diabĂ©ticos o sin estas comorbilidades preoperatorias mujeres. Pacientes y mĂ©todos: Los autores realizaron un estudio retrospectivo de 200 mujeres sometidas a bypass gĂĄstrico en Y de Roux (BGYR), con edades comprendidas entre 20 y 45 años, con un Ăndice de masa corporal (IMC) superior a 35 kg/m2, con hipertensiĂłn arterial (HA, n = 70), la diabetes mellitus tipo 2 (DM2, n = 40) y sin comorbilidades (SC, n = 90) fueron evaluados antes y 6 meses despuĂ©s de BGYR. AntropomĂ©tricas, de laboratorio (ferritina sĂ©rica y hemoglobina) y la informaciĂłn de comorbilidad se recogiĂł de la historia clĂnica electrĂłnica. Resultados: Antes de la cirugĂa, las mujeres con comorbilidades eran mayores, tenĂan mayores hipertensos IMC, niveles mĂĄs altos de ferritina diabĂ©ticos en relaciĂłn con el grupo SC. La resoluciĂłn de las comorbilidades despuĂ©s de 6 meses de DGYR ocurriĂł en el 68 % de las mujeres con hipertensiĂłn y el 86 % de los diabĂ©ticos. 6 meses despuĂ©s de la cirugĂa, se observĂł una disminuciĂłn de la ferritina sĂ©rica en mujeres con comorbilidades de 110,1 ± 86,3 a 88,7 ± 80,5 ng/dl en el grupo con hipertensiĂłn y 164,8 ± 133,4 a 101 2 ± 97,7 ng/dl en DM2 (p < 0,05) y la hemoglobina, excepto en los pacientes diabĂ©ticos (p > 0,05). ConclusiĂłn: El aumento de la ferritina en mujeres obesas en el periodo de premenopausia se relacionan con las principales comorbilidades de la obesidad, y la presencia de estas comorbilidades fue fundamental en la reducciĂłn de la ferritina sĂ©rica despuĂ©s de la cirugĂa bariĂĄtrica.
Descrição
Idioma
InglĂȘs
Citação
Nutricion Hospitalaria, v. 31, n. 2, p. 666-671, 2015.






